Treatment of patients with active Crohn's disease with the TNF inhibitor infliximab has been reported to reduce gut inflammation and largely restore the gut barrier, underscoring the important role of TNF in IBD [8], [9]. This evidence concerns the gene TNF and Crohn disease.